Neurology ReviewsNfL beats T-tau as a prognostic marker of cognitive declineApril 29, 2021Alzheimer's & Cognition
Neurology ReviewsRituximab benefits seen in neuropsychiatric lupusApril 29, 2021Epilepsy & SeizuresHeadache & MigraineAlzheimer's & Cognition
Neurology ReviewsAre psychiatric disorders a ‘canary in a coal mine’ for Alzheimer’s disease?April 27, 2021Alzheimer's & Cognition
Neurology ReviewsSimple blood test plus AI may flag early-stage Alzheimer’s diseaseApril 6, 2021Alzheimer's & Cognition
Neurology ReviewsA paleolithic raw bar, and the human brush with extinctionMarch 26, 2021Alzheimer's & Cognition
Neurology ReviewsCannabinoids promising for improving appetite, behavior in dementiaMarch 23, 2021Alzheimer's & CognitionSleep Medicine
Neurology ReviewsDespite risks and warnings, CNS polypharmacy is prevalent among patients with dementiaMarch 16, 2021Alzheimer's & Cognition
Neurology ReviewsNovel Alzheimer’s drug slows cognitive decline in phase 2 trialMarch 16, 2021Alzheimer's & Cognition
Neurology ReviewsPalliative care for patients with dementia: When to refer?March 10, 2021Alzheimer's & Cognition
Neurology ReviewsSleep apnea and cognitive impairment are common bedfellowsMarch 5, 2021Alzheimer's & CognitionSleep Medicine
Neurology ReviewsNeurologic disorders ubiquitous and rising in the U.S.March 2, 2021Alzheimer's & CognitionEpilepsy & SeizuresHeadache & MigraineMovement DisordersMultiple SclerosisNeuromuscular DisordersParkinson's Disease
Neurology ReviewsCore feature of frontotemporal dementia may aid diagnosisFebruary 25, 2021Alzheimer's & Cognition
Neurology ReviewsFDA extends review period for anticipated Alzheimer’s drugFebruary 4, 2021Alzheimer's & Cognition
Neurology ReviewsCognitive effects seen as transient for Alzheimer’s drug atabecestatFebruary 3, 2021Alzheimer's & Cognition
